The Human Papilloma Virus Testing Market is set to grow from USD 1.76 Billion in 2024 to USD 3.72 Billion by 2030, driven by a 13.60% CAGR. Rising screenings, at-home testing kits, and technological ...

While HPV is often associated with cervical cancer in women, it also causes several serious diseases in men, including penile ...

China approved its first domestically developed nine-valent human papillomavirus (HPV) vaccine on Thursday, according to the ...

Scientists in Uruguay have found genotypes of the human papillomavirus (HPV) linked to cervical cancer in urban wastewater, ...

The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...

Routine ultrasonography may trigger needless biopsies and hysteroscopies, say experts on quaternary prevention in cancer care ...

India grapples with high HPV-related disease burden, emphasizing awareness, prevention, and vaccination to combat cervical ...

The wand developed by Teal Health allows patients to self-collect a vaginal sample and mail it to a lab for testing.

Research has shown that the 4CMenB vaccine provides some protection against an infection from the Neisseria gonorrhoeae ...

Human papillomavirus (HPV) is necessary for the development of cervical carcinoma, and incorporation of molecular testing for HPV in screening and patient management has been proposed. Sufficient ...

Secretary Teodoro Herbosa on Wednesday affirmed the agency's commitment to strengthening the country’s routine immunization ...